Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME.

Phan, Tri Giang; Weilbaecher, Katherine N; Aft, Rebecca; Croucher, Peter I; Chaffer, Christine L

Phan, Tri Giang; Weilbaecher, Katherine N; Aft, Rebecca; Croucher, Peter I; Chaffer, Christine L.

Afiliação

Phan TG; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Weilbaecher KN; St. Vincent's Healthcare Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Darlinghurst, New South Wales, Australia.
Aft R; Department of Medicine and Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
Croucher PI; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Chaffer CL; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

Cancer Discov ; 14(4): 643-647, 2024 Apr 04.

Article em En | MEDLINE | ID: mdl-38571433

ABSTRACT

ABSTRACT

SUMMARY:

Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.

Assuntos

Neoplasias; Humanos; Neoplasias/terapia; Microambiente Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google